Houston Nobel Prize nominee earns latest award for public health research

Prized Research

Dr. Peter Hotez with Dr. Maria Elena Bottazzi. Photo courtesy of TMC

Houston vaccine scientist Dr. Peter Hotez can add one more prize to his shelf.

Hotez — dean of the National School of Tropical Medicine and professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, co-director of the Texas Children’s Center for Vaccine Development (CVD) and Texas Children’s Hospital Endowed Chair of Tropical Pediatrics — is no stranger to impressive laurels. In 2022, he was even nominated for a Nobel Peace Prize for his low-cost COVID vaccine.

His first big win of 2025 is this year’s Hill Prize, awarded by the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST).

Hotez and his team were selected to receive $500,000 from Lyda Hill Philanthropies to help fund The Texas Virosphere Project. The endeavor was born to help create a predictive disease atlas relating to climate disasters. Because the climate crisis has ushered in changes to the distribution of diseases, including dengue, chikungunya, Zika, Chagas disease, typhus and tick-borne relapsing fever, it’s important to predict outbreaks before they become a menace.

Rice University researchers are collaborating with Hotez and his team on a project that combines climate science and metagenomics to access 3,000 insect genomes. The goal is to aid health departments in controlling disease and informing policy.

The Hill Prize, which is being awarded to six innovators for the first time, thanks to a $10 million commitment from the philanthropic organization, is intended to back ideas that are high-risk and high-reward. Each of the projects was chosen for its potential real-life impact on some of Texas's — and the world’s — most challenging situations. Hotez’s prize is the first Hill Prize to be given in the realm of public health. The additional winners are:

  • Hill Prize in Medicine: Kenneth M. Hargreaves, D.D.S., Ph.D., The University of Texas Health Science Center at San Antonio
  • Hill Prize in Engineering: Joan Frances Brennecke, Ph.D. (NAE), The University of Texas at Austin
  • Hill Prize in Biological Sciences: David J. Mangelsdorf, Ph.D. (NAM, NAS), UT Southwestern Medical Center
  • Hill Prize in Physical Sciences: James Chelikowsky, Ph.D., The University of Texas at Austin
  • Hill Prize in Technology: Robert De Lorenzo, M.D., EmergenceMed, LLC
Read about other Houston-area researchers recognized by TAMEST here.
From Your Site Articles
Do you think you know the best of Houston's innovation community? Now's your chance to shine the spotlight on a deserving innovator. Photo by Emily Jaschke/InnovationMap

Nominations launch, tickets open for 2024 Houston Innovation Awards

call for submissions

Update: The nomination period has closed. The originally article is below.

Calling all Houston innovators — InnovationMap needs your help identifying the best and brightest in the Houston innovation ecosystem.

For the fourth year, InnovationMap is hosting its signature awards program that will recognize the top startups and innovators in Houston. The awards program will be on Thursday, November 14, at the Texas Medical Center's Helix Park. Tickets and tables are on sale now.

The nomination period — which includes submitting nominations on behalf of yourself or others — will close September 10. Nominees will be sent an application, which will be due September 23. A panel of judges will review the applications and finalists will be announced and notified ahead of the event.

This year's categories include a few new awards — as well as the return of some crowd favorites. Nominees can be submitted to multiple categories. The 2024 Houston Innovation Awards include:

  • Minority-founded business, honoring an innovative startup founded or co-founded by BIPOC or LGBTQ+ representation
  • Female-founded business, honoring an innovative startup founded or co-founded by a woman
  • Energy transition business, honoring an innovative startup providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond
  • Health tech business, honoring an innovative startup within the health and medical technology
  • Deep tech business, honoring an innovative startup providing technology solutions based on substantial scientific or engineering challenges
  • AI/data science business, honoring an innovative startup utilizing artificial intelligence and data science within a tech solution
  • Scaleup of the year, honoring an innovative later stage startup that's recently reached a significant milestone in company growth
  • Community champion organization, honoring a corporation, nonprofit, university, or other organization that plays a major role in the Houston innovation community
  • People’s choice: Startup of the Year, a startup celebrating a recent milestone or success and the winner will be selected by the community via online portal and announced at the event
  • Ecosystem builder, honoring an individual who has acted as a leader in developing Houston’s startup ecosystem
  • Investor of the year, honoring an individual who is leading venture capital or angel investing
  • Mentor of the year, honoring an individual who dedicates their time and expertise to guide and support to budding entrepreneurs

Additionally, the awards gala will honor an innovator who's made a lasting impact on the Houston innovation community. While you may nominate an individual for the Trailblazer Award via the online form, the judging committee will not require applications or nominations for this category and will be considering potential honorees from the ecosystem at large.

If you are interested in sponsorship opportunities, including the opportunity to sponsor any of the above award categories, please reach out to sales@innovationmap.com.

Eight Houston entrepreneurs are among 16 recipients of EOY’s Gulf South Award, which recognizes leaders of high-growth companies in Central Texas, South Texas, Louisiana, and Mississippi. Photo via Getty Images

8 Houston entrepreneurs recognized on annual EY awards program

regional winners

Eight Houston-area entrepreneurs have been named regional winners in Ernst & Young’s 2024 Entrepreneur Of The Year program.

The eight entrepreneurs are among 16 recipients of EOY’s Gulf South Award, which recognizes leaders of high-growth companies in Central Texas, South Texas, Louisiana, and Mississippi.

A panel of judges chose the winners based on factors such as:

  • Creation of long-term value through entrepreneurship.
  • Commitment to the purpose of their business.
  • Demonstration of growth and “substantial impact.”

“The 2024 Entrepreneur Of The Year Gulf South Award winners are exceptional business leaders fueling innovation within their industries and growth within their companies,” says Anna Horndahl, an EY partner who is co-director of EOY’s Gulf South program.

The Houston area’s Gulf South winners for 2024 are:

  • Hal Brumfield of Tachus Fiber Internet, a provider of fiber-to-the-home internet service based in The Woodlands.
  • Stuart Hinchen and Peter Jenkins of QuVa Pharma, a Sugar Land-based provider of ready-to-administer injectables.
  • Andrew Levy of Avelo Airlines, a low-cost airline based in Houston.
  • Derek Maetzold of Castle Biosciences, a Friendswood-based provider of diagnostic tests.
  • Shannon Payne of Allied Fire Protection, a Pearland-based provider of fire prevention products and services.
  • John Poindexter of JB Poindexter & Co., a Houston-based provider of automotive and manufacturing goods and services.
  • Ting Qiao of Wan Bridge, a Houston-based developer and operator of build-to-rent communities.

“These entrepreneurs are shining examples of how to lead a scaling business and also care for their employees, customers and communities,” says Travis Garms, an EY partner who is co-director of EOY’s Gulf South program.

The regional winners now qualify for consideration in the EOY national awards program. The national awards are scheduled to be presented in November.

Ellen Ochoa, the former center director and astronaut at the NASA's Johnson Space Center in Houston, and Jane Rigby (pictured), senior project scientist for NASA’s James Webb Space Telescope, were honored at the White House on May 3. Photo via the White House

Female leaders from NASA receive presidential awards

space medals

Two astronauts recently received Presidential Medals of Freedom from President Joe Biden for their leadership in space.

Ellen Ochoa, the former center director and astronaut at the NASA's Johnson Space Center in Houston, and Jane Rigby, senior project scientist for NASA’s James Webb Space Telescope, were honored at the White House on May 3.

Ochoa was recognized for her leadership at NASA Johnson and for being the first Hispanic woman in space. Rigby was honored for her work on leading NASA’s transformational space telescope.

Ochoa spent 30 years with NASA, which included being the 11th director of JSC, deputy center director of JSC, and director of Flight Crew Operations. She served on the nine-day STS-56 mission aboard the space shuttle Discovery in 1993, and became the first Hispanic woman in space. She flew four more times to space with STS-66, STS-96, STS-110, and more.

“I’m so grateful for all my amazing NASA colleagues who shared my career journey with me,” Ochoa says in a NASA news release.

Rigby has published 160 peer-reviewed publications. She has been recognized with various awards like NASA’s Exceptional Scientific Achievement Medal, the Fred Kavli Prize Plenary Lecture from the American Astronomical Society (AAS), and the 2022 LGBTQ+ Scientist of the Year from Out to Innovate. Currently, she is an astrophysicist at NASA’s Goddard Space Flight Center.

Part of Rigby’s Medal of Freedom honor is due to her role in the success of NASA’s Webb mission. Webb is considered the most powerful space telescope, which launched on Dec. 25, 2021.

“I am proud Ellen and Jane are recognized for their incredible roles in NASA missions, for sharing the power of science with humanity, and inspiring the Artemis Generation to look to the stars,” says NASA Administrator Bill Nelson in the release. “Among her many accomplishments as a veteran astronaut and leader, Ellen served as the second female director of Johnson, flew in space four times, and logged nearly 1,000 hours in orbit. Jane is one of the many wizards at NASA who work every day to make the impossible possible. The James Webb Space Telescope represents the very best of scientific discovery that will continue to unfold the secrets of our universe. We appreciate Ellen and Jane for their service to NASA, and our country.”

Do you think you know the best of Houston's innovation community? Now's your chance to shine the spotlight on a deserving innovator. Photo via Getty Images

Deadline extended: Nominations open for InnovationMap's 2023 Houston Innovation Awards

call for submissions

InnovationMap has extended the nomination deadline to September 22 at midnight. The original article appears below.

We're looking to highlight the best in Houston innovation — do you think you know who has what it takes?

For the third year, InnovationMap is hosting an awards program that will recognize the best of the rest in Houston's innovation ecosystem. Again collaborating with Houston Exponential, the awards program will be on Wednesday, November 8, at Silver Street Studios.

The nomination period — which includes submitting nominations on behalf of yourself or others — will close September 19. Nominees will be sent an application, which will be due October 4. A panel of judges will review the applications and finalists will be announced and notified ahead of the event.

This year's categories include a few new awards — as well as the return of some crowd favorites. Nominees can be submitted to multiple categories.The 2023 Houston Innovation Awards include:

  • BIPOC-Owned Business, honoring an innovative company founded or co-founded by BIPOC representation
  • Female-Owned Business, honoring an innovative company founded or co-founded by a woman
  • Hardtech Business, honoring an innovative company developing and commercializing a physical technology
  • Digital Solutions Business, honoring an innovative company developing and programming a digital solution to a problem in an industry
  • Social Impact Business, honoring an innovative company providing a solution that would enhance humanity or society in a significant way
  • Sustainability Business, honoring an innovative company providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond
  • Life Science Business, honoring an innovative company within the health and medical industries designing a treatment or technology
  • Corporate of the Year, honoring a corporation that supports startups and/or the Houston innovation community
  • DEI Champion, honoring an individual who is leading impactful diversity, equity, and inclusion initiatives and progress within Houston and their organization
  • Ecosystem Builder, honoring an individual who has acted as a leader in developing Houston’s startup ecosystem
  • Mentor of the Year, honoring an individual who dedicates their time and expertise to guide and support to budding entrepreneurs
  • People's Choice: Startup of the Year, selected via an interactive voting portal during the event

Additionally, the awards gala will honor an innovator who's made a lasting impact on the Houston innovation community. While you may nominate an individual for the Trailblazer Award via the online form, the judging committee will not require applications or nominations for this category and will be considering potential honorees from the ecosystem at large.

If you are interested in sponsorship opportunities, please reach out to misti@gowmedia.com.

Click here to submit a nomination or see form below.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Texas tops ranking of best state for investors in new report

by the numbers

Texas ranks third on a new list of the best states for investors and startups.

Investment platform BrokerChooser weighed five factors to come up with its ranking:

  • 2024 Google search volume for terms related to investing
  • Number of investors
  • Number of businesses receiving investments in 2024
  • Total amount of capital invested in businesses in 2024
  • Percentage change in amount of investment from 2019 to 2024

Based on those figures, provided mostly by Crunchbase, Texas sits at No. 3 on the list, behind No. 1 California and No. 2 New York.

Especially noteworthy for Texas is its investment total for 2024: more than $164.5 billion. From 2019 to 2024, the state saw a 440 percent jump in business investments, according to BrokerChooser. The same percentages are 204 percent for California and 396 percent for New York.

“There is definitely development and diversification in the American investment landscape, with impressive growth in areas that used to fly under the radar,” says Adam Nasli, head analyst at BrokerChooser.

According to Crunchbase, funding for Texas startups is off to a strong start in 2025. In the first three months of this year, venture capital investors poured nearly $2.9 billion into Lone Star State companies, Crunchbase data shows. Crunchbase attributes that healthy dollar amount to “enthusiasm around cybersecurity, defense tech, robotics, and de-extincting mammoths.”

During the first quarter of this year, roughly two-thirds of VC funding in Texas went to just five companies, says Crunchbase. Those companies are Austin-based Apptronik, Austin-based Colossal Biosciences, Dallas-based Island, Austin-based NinjaOne, and Austin-based Saronic.

Autonomous truck company rolls out driverless Houston-Dallas route

up and running

Houston is helping drive the evolution of self-driving freight trucks.

In October, Aurora opened a more than 90,000-square-foot terminal at a Fallbrook Drive logistics hub in northwest Houston to support the launch of its first “lane” for driverless trucks—a Houston-to-Dallas route on the Interstate 45 corridor. Aurora opened its Dallas-area terminal in April and the company began regular driverless customer deliveries between the two Texas cities on April 27.

Close to half of all truck freight in Texas moves along I-45 between Houston and Dallas.

“Now, we are the first company to successfully and safely operate a commercial driverless trucking service on public roads. Riding in the back seat for our inaugural trip was an honor of a lifetime – the Aurora Driver performed perfectly and it’s a moment I’ll never forget,” Chris Urmson, CEO and co-founder of Pittsburgh-based Aurora, said in a news release.

Aurora produces software that controls autonomous vehicles and is known for its flagship product, the Aurora Driver. The software is installed in Volvo and Paccar trucks, the latter of which includes brands like Kenworth and Peterbilt.

Aurora previously hauled more than 75 loads per week under the supervision of vehicle operators from Houston to Dallas and Fort Worth to El Paso for customers in its pilot project, including FedEx, Uber Freight and Werner. To date, it has completed over 1,200 miles without a driver.

The company launched its new Houston to Dallas route with customers Uber Freight and Hirschbach Motor Lines, which ran supervised commercial pilots with Aurora.

“Transforming an old school industry like trucking is never easy, but we can’t ignore the safety and efficiency benefits this technology can deliver. Autonomous trucks aren’t just going to help grow our business – they’re also going to give our drivers better lives by handling the lengthier and less desirable routes,” Richard Stocking, CEO of Hirschbach Motor Lines, added in the statement.

The company plans to expand its service to El Paso and Phoenix by the end of 2025.

“These new, autonomous semis on the I-45 corridor will efficiently move products, create jobs, and help make our roadways safer,” Gov. Greg Abbott added in the release. “Texas offers businesses the freedom to succeed, and the Aurora Driver will further spur economic growth and job creation in Texas. Together through innovation, we will build a stronger, more prosperous Texas for generations.”

In July, Aurora said it raised $820 million in capital to fuel its growth—growth that’s being accompanied by scrutiny.

In light of recent controversies surrounding self-driving vehicles, the International Brotherhood of Teamsters, whose union members include over-the-road truckers, recently sent a letter to Lt. Gov. Dan Patrick calling for a ban on autonomous vehicles in Texas.

“The Teamsters believe that a human operator is needed in every vehicle—and that goes beyond partisan politics,” the letter states. “State legislators have a solemn duty in this matter to keep dangerous autonomous vehicles off our streets and keep Texans safe. Autonomous vehicles are not ready for prime time, and we urge you to act before someone in our community gets killed.”

Houston cell therapy company launches second-phase clinical trial

fighting cancer

A Houston cell therapy company has dosed its first patient in a Phase 2 clinical trial. March Biosciences is testing the efficacy of MB-105, a CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma.

Last year, InnovationMap reported that March Biosciences had closed its series A with a $28.4 million raise. Now, the company, co-founded by Sarah Hein, Max Mamonkin and Malcolm Brenner, is ready to enroll a total of 46 patients in its study of people with difficult-to-treat cancer.

The trial will be conducted at cancer centers around the United States, but the first dose took place locally, at The University of Texas MD Anderson Cancer Center. Dr. Swaminathan P. Iyer, a professor in the department of lymphoma/myeloma at MD Anderson, is leading the trial.

“This represents a significant milestone in advancing MB-105 as a potential treatment option for patients with T-cell lymphoma who currently face extremely limited therapeutic choices,” Hein, who serves as CEO, says. “CAR-T therapies have revolutionized the treatment of B-cell lymphomas and leukemias but have not successfully addressed the rarer T-cell lymphomas and leukemias. We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.”

The Phase 1 trial showed promise for MB-105 in terms of both safety and efficacy. That means that potentially concerning side effects, including neurological events and cytokine release above grade 3, were not observed. Those results were published last year, noting lasting remissions.

In January 2025, MB-105 won an orphan drug designation from the FDA. That results in seven years of market exclusivity if the drug is approved, as well as development incentives along the way.

The trial is enrolling its single-arm, two-stage study on ClinicalTrials.gov. For patients with stubborn blood cancers, the drug is providing new hope.

View All Listings